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ABSTRACT
Riboswitches have gained attention as tools for
synthetic biology, since they enable researchers to
reprogram cells to sense and respond to exoge-
nous molecules. In vitro evolutionary approaches
produced numerous RNA aptamers that bind such
small ligands, but their conversion into functional
riboswitches remains difficult. We previously devel-
oped a computational approach for the design of syn-
thetic theophylline riboswitches based on secondary
structure prediction. These riboswitches have been
constructed to regulate ligand-dependent transcrip-
tion termination in Escherichia coli. Here, we test the
usability of this design strategy by applying the ap-
proach to tetracycline and streptomycin aptamers.
The resulting tetracycline riboswitches exhibit ro-
bust regulatory properties in vivo. Tandem fusions
of these riboswitches with theophylline riboswitches
represent logic gates responding to two different in-
put signals. In contrast, the conversion of the strepto-
mycin aptamer into functional riboswitches appears
to be difficult. Investigations of the underlying ap-
tamer secondary structure revealed differences be-
tween in silico prediction and structure probing.
We conclude that only aptamers adopting the min-
imal free energy (MFE) structure are suitable tar-
gets for construction of synthetic riboswitches with
design approaches based on equilibrium thermody-
namics of RNA structures. Further improvements in
the design strategy are required to implement ap-
tamer structures not corresponding to the calculated
MFE state.
INTRODUCTION
Riboswitches are non-coding RNA molecules regulating
gene expression in response to binding of small ligand
molecules. As they have no need for additional protein fac-
tors, riboswitches represent a valuable tool for gene regula-
tion in the field of synthetic biology. Since their first discov-
ery in 2002 (1–3), around 20 riboswitch classes have been de-
scribed (4,5). Located mostly in the 5′-UTR of prokaryotic
mRNAs, riboswitches bind ligands with high affinity and
specificity. Regulation of gene expression includes mecha-
nisms such as transcription termination, translation initia-
tion and control of mRNA self-cleavage (6,7). Despite these
mechanistic differences, all riboswitches share a common
layout consisting of two domains: the aptamer region binds
the target molecule and acts as the sensory domain, while
the regulatory or effector domain influences gene expres-
sion (7,8). This modular nature of riboswitches holds the
potential for constructing synthetic riboswitches and repro-
gramming cells by replacing the aptamer domain with an-
other aptamer–ligand-pair (9). In vitro selection procedures
like SELEX enable researchers to isolate aptamer sequences
that in theory can target any desired ligand molecule, ren-
dering synthetic riboswitches an ideal tool to manipulate
gene expression at the level of transcription or translation
(10–12).
However, most of the selected aptamer-ligand pairs are
not suitable for artificial riboswitches, as many ligands are
not cell-permeable or toxic for the target organism, or
their antibiotic character limits their use to eukaryotic or-
ganisms. As a consequence, only few in vitro selected ap-
tamers have been incorporated in synthetic riboswitches,
e.g. for neomycin (13–15), theophylline (16–20) and tetra-
cycline (21–23). Other strategies use combinations of natu-
ral aptamer domains and expression platforms as chimeric
riboswitches (24,9) or modified aptamers recognizing lig-
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and analogues orthogonally to their natural counterparts
(25,26). For the vast majority of in vitro selected aptamers,
the conversion into new synthetic riboswitches remains dif-
ficult, since the fusion to the expression platforms resulting
in functional regulatory devices is rarely straight-forward.
Since most natural effector domains have specific sequence
requirements, they do not function well in combination with
aptamer domains other than their natural counterparts they
co-evolved with. As a consequence, the creation of func-
tional riboswitches often involves adaptation of the effector
domain, e.g. by randomization of sequence parts and sub-
sequent in vitro or in vivo selection and screening processes
(27,28). Hence, several recent studies focus on RNA regula-
tors that do not contain an aptamer domain and act in trans,
like toehold switches (29) or small trans activating RNAs
(30,31). Yet, synthetic riboswitches acting in cis have sev-
eral important advantages over trans-acting RNA regula-
tors. Trans-regulating RNAs clearly show a concentration-
dependent efficiency and usually are required at high copy
numbers in the cell. Further, they can have considerable side
effects, when mRNAs other than the target transcript are
bound as well. Riboswitches do not exhibit such off-target
effects and show a high speed of response, as their regula-
tion mode occurs exclusively in cis.
Recently, the implementation of aptamers into synthetic
cis-acting riboswitches has been improved by several ra-
tional approaches. Computational methods based on sec-
ondary structure and folding prediction circumvent the
need for large sequence libraries (19,24,32). In a de novo
design strategy, a theophylline aptamer sequence was com-
bined with a downstream located synthetic terminator se-
quence and fused to the 5′-UTR of a reporter gene (19). This
resulted in functional synthetic riboswitches in Escherichia
coli, regulating transcription termination in a theophylline-
dose-dependent way. The riboswitches have been employed
for conditional gene expression of -galactosidase and
eGFP reporters and operate under the control of inducible
(PBAD) as well as constitutive promoters (Prrn) (19,33).
Here, we investigate the applicability of this design principle
and replace the input (aptamer) domain of these synthetic
riboswitches by in vitro selected aptamers for tetracycline
and streptomycin (34,35). Furthermore, we designed a logic
AND gate consisting of theophylline- and tetracycline-
dependent riboswitches and identified important pitfalls




Oligonucleotides were obtained from biomers.net, dNTPs
from Jena Biosciences and [ -32P]-ATP from Hartmann
Analytic. LB medium was purchased from AppliChem.
ONPG, streptomycin sulphate salt, doxycycline hydrochlo-
ride, tetracycline hydrochloride and theophylline were ob-
tained from Sigma Aldrich. Ampicillin and arabinose were
purchased from Carl Roth.
In silico design of synthetic riboswitches
A rational design algorithm was used to predict riboswitch
sequences for the streptomycin (35) and tetracycline (34)
aptamer as previously described for the design of syn-
thetic theophylline riboswitches (19). Spacer sequences and
lengths were randomized, and terminator 3′-parts adapted
accordingly. Calculations of free energy values and sec-
ondary structure predictions were performed with the
RNAfold program of the Vienna RNA package (36).
Plasmid construction
Riboswitch DNA constructs were generated by overlap
extension polymerase chain reaction (PCR) and fused
into the 5′-UTR of a bgaB reporter gene in pBAD2-
bgaBshift (19) by site-directed mutagenesis PCR. Serial ar-
rangements of Tet–RS constructs were generated by site-
directed mutagenesis and fused to the bgaB reporter gene
in pBAD2 bgaBshift, according to Wachsmuth et al. (33).
Sequences of riboswitch constructs used in this study are
shown in Supplementary Table S1.
Resistance of E. coli Top10 cells to tetracycline was
achieved by co-expression of the ribosomal protection
protein TetM together with tetracycline riboswitches. For
this purpose, the on-site cat gene of pACYCDuet™-1
(Novagen/EMD Millipore) was replaced with a tetM gene
from Enterococcus faecalis (37) by restriction cloning with
SpeI and XmaI, resulting in a new pACYC-tetM vector
(Supplementary Figure S1). Primers used for this cloning
strategy are shown in Supplementary Table S2.
Quantitative analysis of -galactosidase activity
Quantitative analysis of -galactosidase activity was per-
formed in 2–3 independent experiments according to
Wachsmuth et al. (19), using tetracycline- or streptomycin-
resistant E. coli Top10 (F- mcrA (mrr-hsdRMS-mcrBC)
80lacZM15 lacX74 recA1 araD139 (ara-leu) 7697
galU galK rpsL (StrR) endA1 nupG -) with starter cul-
tures grown between 16 and 24 h to obtain identical OD600.
Activation rates were calculated separately for each con-
struct as Miller units (MU) in the presence of ligand divided
by MU in absence of ligand.
Structural probing of RNA
Streptomycin aptamer and Strep-RS7 RNAs were gener-
ated by in vitro transcription with T7 RNA polymerase
and subsequent polyacrylamide (PAA) gel purification and
ethanol precipitation. RNA 5′-ends were dephosphorylated
using antarctic phosphatase (NEB) and labeled with [ -
32P]-ATP (Hartmann Analytic) using T4 polynucleotide ki-
nase (NEB) according to manufacturer’s protocols. Struc-
tural analysis of 10 000 cpm 5′-end labeled RNA per reac-
tion was performed via in-line probing (38) in the presence
of 50 mM Tris-HCl (pH 8.5), 12 mM MgCl2, 0.1 mg/ml
tRNA from E. coli MRE 600 (Roche Diagnostics) and 0–10
mM streptomycin. All purification steps were carried out on
12.5% or 15% denaturing PAA gels. Imaging of 32P-labeled
RNA was performed with a Typhoon 9410 Variable Imager
(GE Healthcare).
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RESULTS
In silico design of synthetic riboswitches
In a previous study, synthetic riboswitches regulating tran-
scription termination in a theophylline-dependent way in
E. coli were constructed with a computational approach
based on secondary structure prediction (19). To investigate
the usability of this design strategy with different SELEX-
derived aptamer elements, we applied this approach for the
generation of synthetic riboswitches based on tetracycline
and streptomycin aptamers (34,35) (Figure 1).
According to the recently described design parameters
(19,33), riboswitch candidates were constructed based on
randomly generated spacer sequences with lengths between
6 and 20 nucleotides (nts). Intrinsic terminator hairpins
were formed by combining these spacers with sequences
that exhibit perfect complementarity to the 3′-part of the
aptamer. The terminators were completed by an immedi-
ately downstream located stretch of eight U residues (U8).
For the tetracycline aptamer, the start position of the com-
plementary region was shifted from 34 to 59 and from 23
to 36 for the streptomycin aptamer. In brief, the design ap-
proach consists of a candidate generation and an in silico
evaluation step. Initial prediction and filtering resulted in 25
tetracycline and 11 streptomycin riboswitch candidates, re-
spectively. For these tetracycline candidates, spacer lengths
varied from 6 to 18 and start positions of the complemen-
tary region ranged from position 43 to 49. The correspond-
ing numbers for streptomycin are 6 to 15 and 33 to 36.
The most promising candidates were cloned into a pBAD2-
bgaBshift vector (19) and tested in E. coli Top10 cells for
their ability to regulate gene expression of a downstream
bgaB reporter.
Design and activity test of tetracycline riboswitch reporter
constructs
For the in silico design of synthetic riboswitches responding
to tetracycline, the well-characterized aptamer cb32sh (34)
was chosen as sensing platform. Conformation and ligand-
binding of this aptamer have been studied extensively by
structure probing (39), ITC (40), EPR (41) and fluorescence
spectroscopy (42), showing a strong similarity to the min-
imal free energy (MFE) structure predicted by RNAfold
(36,43) (Figure 2A).
Based on this MFE structure, the prediction yielded a
set of potential riboswitch candidates (Figure 1B). Tet-RS1,
Tet-RS2 and Tet-RS3 were cloned into the 5′-UTR of a
bgaB reporter and tested for tetracycline-dependent gene
regulation. In E. coli, all three candidates respond to tetra-
cycline in the medium (2.5 g/ml) and show a 1.8-, 2.2-
and 1.5-fold increase in -galactosidase activity, respec-
tively (Figure 2A). Hence, these constructs represent func-
tional riboswitches.
To achieve a higher ligand response ratio, the tetracy-
cline riboswitches were further optimized, based on our ex-
perimental experience with the theophylline riboswitches
(19,33). In these studies, we demonstrated that constructs
can be improved by adjusting the stability of the termina-
tor hairpin relative to the aptamer domain (19,33). Due to
the size (69 nts) and stability (G = −19.8 kcal/mol) of
the tetracycline aptamer, terminator hairpins of the corre-
sponding riboswitches have to be more stable than termina-
tors in theophylline riboswitches (theophylline aptamer: 42
nts, G = −12.2 kcal/mol) in order to compete with the
aptamer structure. As Tet-RS2 showed the best response
ratio in the initial -galactosidase activity test, this con-
struct was further optimized by destabilization of the corre-
sponding terminator hairpin. A similar approach involving
base pair deletions successfully converted a non-functional
theophylline-specific riboswitch into a functional construct
(33). However, in the case of Tet-RS2, it was not possible
to delete complete base pairs at the top of the terminator
stem, since these nucleotides are part of the tetracycline ap-
tamer (Figure 2A). Instead, the hairpin was shortened by
stepwise deletion of 3′-terminal sequences of the aptamer-
complementary region, resulting in Tet-RS2-17, Tet-RS2-
15, Tet-RS2-13 and Tet-RS2-10 (numbers indicate remain-
ing base pairs in the terminator hairpin; Figure 2B). For
cloning reasons, a shorter version of the tetracycline ap-
tamer was used, where nucleotides 19–36 have been replaced
by a GAAA tetraloop, resulting in the cb32sh minimer (40).
This tetracycline minimer displays the same folding and
binding characteristics as the parental aptamer and does
not affect riboswitch functionality, as a -galactosidase ac-
tivity test showed almost identical MU values and activa-
tion rates as in a comparable full-length construct (Supple-
mentary Figure S2).
Quantitative analysis of -galactosidase activity of these
terminator hairpin deletion variants revealed that Tet-RS2-
17, Tet-RS2-15 and Tet-RS2-13 display similar background
activities as Tet-RS2 in the absence of tetracycline, but
show significantly higher MU values in the presence of the
ligand, leading to increased response ratios of 2.5-, 3.4-
and 3.0-fold, respectively (Figure 2B). Obviously, a medium
terminator stem length of 15 bp leads to the most effi-
cient tetracycline-dependent riboswitch regulation. A fur-
ther shortening of the hairpin down to 10 bp abolishes ter-
minator function and, consequently, riboswitch-mediated
regulation of bgaB gene expression, resulting in constitu-
tive gene expression, even in the absence of tetracycline
(Tet-RS2-10, Figure 2B). These results are in agreement
with those observed for synthetic theophylline riboswitches
(19,33).
A further way to optimize the ligand response is to com-
bine several repeats of the riboswitch construct 5′ of the
gene to be regulated. For tandem and tridem repeats of
theophylline riboswitches, we could demonstrate that the
serial arrangement of transcription terminators leads to a
reduced background in gene expression, and, consequently,
to an increase in the ligand-dependent response ratio (33).
To investigate whether this is also true for tetracycline-
dependent riboswitches, we generated serial repeats with
two and three copies of Tet-RS2-15 upstream of the bgaB
reporter gene (Figure 2C). Similar to the theophylline-
riboswitch repeats, both constructs had a further decreased
background activation in the absence of tetracycline, with
values of 10 (TetTet-RS) and 7 MU (TetTetTet-RS), com-
pared to 21 MU for the monomeric riboswitch (Figure
2C). Ligand-dependent gene expression was only slightly
reduced in the riboswitch repeats, resulting in improved re-
sponse ratios of 7.5x (TetTet-RS) and 9.5x (TetTetTet-RS).
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Figure 1. Synthetic riboswitches for regulation of transcription termination in Escherichia coli based on de novo design. (A) Design principle. In the
absence of ligand, the 3′-part of the aptamer domain (red) forms a terminator hairpin with the reverse complementary part (blue), leading to transcription
termination. Binding of the corresponding ligand (full black circle) stabilizes the aptamer conformation and disrupts the terminator structure, enabling
transcription of the reporter gene. (B) Tetracycline-dependent riboswitch (RS) candidates from secondary structure predictions. Sequences include the
tetracycline aptamer ‘cb32sh’ in red (40), a connecting spacer region in cyan, the complementary part for the aptamer in blue and a black U-stretch. Given
below each sequence are the terminator and aptamer conformations in dot-bracket annotation (grey and red bars, respectively). Calculated free energy
values of the competing structures and the terminator elements are indicated. (C) Riboswitch candidates for the streptomycin aptamer ‘motif 1’ (35),
including predicted free energy values. Color code is according to (B).
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Figure 2. Activity tests of synthetic tetracycline riboswitches. (A) Design and activity of in silico predicted constructs. In the presence of 2.5 g/ml tetracy-
cline, expression of -galactosidase was induced in E. coli, resulting in an increase of Miller units (MU). bgaBU8 represents the appropriate positive control
(19,33), consisting of a plasmid expressing the reporter gene under the same promoter but lacking the aptamer and the terminator hairpin. Only the U
stretch is present, as this can have an effect on the reporter gene expression. (B) Optimized Tet-RS2 constructs. The terminator hairpin stability of Tet-RS2
was modified by deleting residues from the 3′-end of the hairpin. In the activity test, these modifications led to an increased response ratio for Tet-RS2-17,
Tet-RS2-15 and Tet-RS2-13, while in Tet-RS2-10, the terminator hairpin is too unstable to compete with the aptamer fold. Accordingly, the construct is in
a constitutive ON state, independent of tetracycline binding. Furthermore, this behavior is a direct indication that the riboswitch constructs regulate at the
level of transcription (19). (C) Serial arrangements of two and three Tet-RS2-15 repeats increase the ligand-dependent responsiveness. The existence of two
or three intrinsic terminator elements leads to a reduction of background gene expression in the absence of tetracycline. While the monomeric Tet-RS2-15
shows an absolute activation of 80 MU that is not further increased by a higher tetracycline concentration, tandem and tridem show a somewhat lower
absolute response (60–80 MU), with some increase at the higher ligand concentration. As a result, the activation ratios for the tandem and tridem are
considerably increased compared to the monomeric riboswitch form.
To demonstrate the tetracycline specificity of the syn-
thetic Tet-RS constructs, the structurally related drug doxy-
cycline was used in a control experiment with Tet-RS2-15.
Doxycycline has the same antibiotic properties as tetracy-
cline, but is not bound by the aptamer and therefore repre-
sents an ideal negative control molecule (44,40,23). As ex-
pected, Tet-RS2-15 showed no doxycycline-dependent acti-
vation of bgaB (Supplementary Figure S3).
These results demonstrate that the in silico design ap-
proach followed by structure-guided experimental opti-
mization can be applied for non-theophylline aptamers as
well, showing that functional transcriptional riboswitches
can be rationally designed not only in the context of differ-
ent promoters or reporter genes, but also for different ap-
tamers.
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Construction and testing of streptomycin riboswitches
In a second experimental setup, a streptomycin aptamer
(35) was subjected to the riboswitch design approach (Fig-
ure 1C). From the resulting 11 candidates, four were cloned
into the pBAD2 bgaBshift vector and tested in the presence
of 1 mg/ml streptomycin in E. coli Top 10 cells carrying an
intrinsic streptomycin resistance based on an altered ribo-
somal target site (S12 protein, rpsL StrR). Hence, as in the
case of the above mentioned tetracycline resistance, the lig-
and is not destroyed or transported out of the cell.
Riboswitch candidates Strep-RS1, Strep-RS4 and Strep-
RS8 showed no response at all to streptomycin, and for
Strep-RS7, only a very moderate 1.5-fold upregulation of
the reporter gene expression was observed (Figure 3). While
Strep-RS1 showed a weak constitutive reporter gene expres-
sion (30–40 MU), Strep-RS4 and Strep-RS8 are in a perma-
nent OFF state (10–15 MU). These values correlate with
the corresponding terminator stabilities (Figure 1C), where
Strep-RS1 carries the least stable hairpin element (G =
−20.7 kcal/mol versus −24.0 kcal/mol and −27.7 kcal/mol
for Strep-RS4 and Strep-RS8, respectively). The terminator
of the slightly active Strep-RS7 has an intermediate stability
(G = −24.4 kcal/mol).
As variation of the streptomycin concentration in the
medium from 0.05 mg/ml up to 5 mg/ml had no effect
on the reporter gene activation (data not shown), the sin-
gle weakly responding construct Strep-RS7 was selected
for structure-guided optimization. Our investigations on
theophylline- and tetracycline-dependent riboswitch con-
structs indicate that the terminator stability is one of the
major factors affecting the regulatory potential of the con-
structs (33). Hence, similar to our strategy for Tet-RS2 con-
structs, the terminator stem of Strep-RS7 was destabilized
by the introduction of mismatch positions and 3′-terminal
deletions (Supplementary Figure S4). However, these mod-
ifications did not improve the functionality of Strep-RS7,
but completely destroyed the modest response ratio ob-
served for the original construct. It seems that in this case
the riboswitch functionality is more dependent on the ap-
tamer platform and its interaction with the ligand than on
the terminator part of the riboswitch, as an impaired ligand
interaction would result in non-functional riboswitches. To
address this question, the structure and ligand-binding ca-
pability of the isolated streptomycin aptamer were analyzed
by structure probing.
Secondary structure analysis of the streptomycin aptamer
The secondary structure of the streptomycin aptamer, rep-
resenting the sensory domain in our riboswitch constructs,
was investigated by in-line probing (38). Starting from a
PCR product with 5′-located T7 promoter, the streptomycin
aptamer RNA was transcribed in vitro, gel-purified and
5′-end labeled with [ -32P]-ATP. In-line probing was per-
formed in the presence of 0–10 mM streptomycin and an-
alyzed by PAA gel electrophoresis. Positions of G residues
were assigned to the aptamer sequence using partial RNase
T1 digestion and alkaline hydrolysis. Regions of high flex-
ibility within the RNA structure are visible as prominent
bands in the gel image and indicated by square brackets
(Figure 4A).
The RNA cleavage pattern indicates a secondary struc-
ture that is in agreement with the previously published
structure (Figure 4B) (35). However, the in silico design and
secondary structure prediction of the synthetic riboswitches
was based on a MFE structure (Figure 4B) which shows
a strong discrepancy to the probed structure. Based on
RNAfold, the underlying design approach includes the
MFE structure in the riboswitch prediction, since it is the
most stable from a set of all possible secondary structures
and has the lowest G value. In contrast, the actual probed
structure is more closely related to a slightly less stable struc-
ture (Figure 4C) and was also obtained when the whole con-
struct Strep-RS7 was probed (data not shown).
Hence, the aptamer as an isolated form as well as in the
riboswitch context exhibits the same folding that is not com-
patible with the predicted MFE structure. For future de-
signs, it will be important to implement naturally occur-
ring non-MFE-like structures of aptamers as a folding con-
straint in order to generate functional riboswitches.
Construction of heterogeneous tandem riboswitches
Natural riboswitches do not invariably consist of one ap-
tamer and one expression platform. Tandem riboswitches
often contain two aptamer domains and show increased
sensitivity and sometimes cooperative binding for their cog-
nate ligand (45–49). Similar tandem combinations were
also generated from synthetic riboswitches, incorporating
signals from two different ligands (50–53). Furthermore,
even tridem arrangements of synthetic transcriptional theo-
phylline riboswitches were designed, showing a considerable
improved response ratio and a dose-dependent linear acti-
vation rate (33).
To investigate the regulatory potential of our designed
riboswitches as a logic AND gate, heterogeneous tandem
riboswitches were produced by combining a theophylline-
sensing riboswitch Theo-RS10 (19; Supplementary Figure
S5A) with tetracycline-binding Tet-RS2-15, both represent-
ing the best performing riboswitches of the two classes.
Theo-RS10 as well as Tet-RS2-15 show both a highly spe-
cific response to their respective ligands, while they are not
activated by the second target molecule (Figure 5). These
ligand-specific riboswitch modules were arranged in both
5′-3′-orders, resulting in tandem constructs TheoTet-RS
and TetTheo-RS (Figure 5). Both tandem arrangements
should activate gene expression of the bgaB reporter only in
the simultaneous presence of both theophylline and tetracy-
cline.
In comparison with the individual riboswitches, the -
galactosidase background activity of both tandem con-
structs is considerably low and does not exceed 5 MU in
the absence of both ligands. As a consequence of a back-
ground close to zero, activation rates are relatively high: in
the presence of both ligands, the activation rates are 10.4-
fold for TheoTet-RS and 7.7-fold for TetTheo-RS (Figure
5). TheoTet-RS indeed functions as a logic AND gate and
shows low reporter gene activities in the presence of the in-
dividual ligands. Here, theophylline leads to an increase to
3 MU, while tetracycline induces the system to 6 MU com-
pared to a zero-ligand background of 1–2 MU (Figure 5).
The presence of both ligands activates the system, result-
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Figure 3. Design and activity test of synthetic streptomycin riboswitches. Measurement of -galactosidase activity in MU was performed in the presence (1
mg/ml) or absence of streptomycin. While constructs Strep-RS 1, 4 and 8 showed no ligand-dependent response, Strep-RS7 exhibited a ligand-dependent
1.5-fold increase in gene expression. bgaBU8: positive control without riboswitch (see legend Figure 2).
Figure 4. Secondary structure analysis of the 5′-labeled streptomycin aptamer transcript. (A) In-line probing analysis. T1: Partial digest with RNase T1.
OH−: Alkaline hydrolysis. 0 h: Transcript without incubation. Lanes 0–10: Transcript was probed in the presence of indicated streptomycin concentra-
tions for 44 h. Regions of high cleavage activity are indicated by brackets. (B) The secondary structure according to probing results is highly similar to
streptomycin aptamer ‘motif 1’ (35) and differs from the in silico predicted structure of minimal free energy (MFE). (C) From the folding predictions of
RNAsubopt (36), a slightly less stable structure with a free energy of −11.0 kcal/mol is highly similar to the probed one, indicating that the approach used
the wrong fold for riboswitch design. Regions of high cleavage activity from structure probing in (A) are depicted as grey circles.
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Figure 5. Design principle and activity test of tandem riboswitches. The individual components Tet-RS2-15 and Theo-RS10 show a highly specific ac-
tivation only in the presence of their cognate ligand. This is not affected by the presence of the second ligand. In the absence of ligands, both tandem
riboswitches TheoTet-RS and TetTheo-RS show a minimal activation of -galactosidase expression. In the presence of theophylline, the order of the ri-
boswitch modules has an impact on background activity, indicating that in TetTheo-RS, the Tet module is affected in its OFF state, leading to a rather
high background activation.
ing in 17 MU. In the case of TetTheo-RS, the tandem is
also fully activated in the presence of both ligands (24 MU;
Figure 5). While tetracycline alone does not induce gene ex-
pression (3–4 MU, representing the background activity of
the Theo-RS part), the addition of theophylline only leads
already to partial activation (17 MU, representing the back-
ground activity of the Tet-RS part). Hence, the TetTheo-RS
construct shows the same tendency as TheoTet-RS, how-
ever, the background activation of the Tet-RS2-15 part (in
the presence of just theophylline) is significantly increased.
Obviously, the Tet terminator seems to be too weak to effi-
ciently shut off transcription before the downstream located
Theo riboswitch is transcribed. This indicates a strong posi-
tioning effect in these constructs where the sequential order
of the individual riboswitch elements has an impact on the
ligand-dependent response.
As only the TheoTet construct exhibited a considerable
functionality as logic ‘AND’ gate, a further structure-guided
optimization of this tandem riboswitch was attempted. To
reduce the Tet-RS2-dependent response background, we
replaced the loop region in the corresponding termina-
tor hairpin by a stabilizing GAAA tetraloop, resulting in
TheoTet-RS2-15loop (Supplementary Figure S5B). This
tetraloop sequence was previously used to increase the ter-
mination efficiency in a theophylline riboswitch (19). In
a second construct, the 10 bp terminator hairpin (Figure
2B) stabilized by additional GC base pairs was introduced.
However, both variants led to a complete repression of gene
expression, independent of the ligands (Supplementary Fig-
ure S5C).
It is possible that the close proximity of both riboswitch
modules interferes with correct folding of the individual
units, so that binding of theophylline to its aptamer struc-
ture affects binding of tetracycline to the other correspond-
ing aptamer. An increased distance between the two ri-
boswitch elements should allow an independent folding of
the individual regions and, consequently, abolish such inter-
ference. Accordingly, computer-generated sequences of 15,
20 and 30 nts length were designed that form an unstruc-
tured linker between the riboswitch modules and that do not
interact with these elements. One of each linker sequence
was inserted between the riboswitch modules in TheoTet-
RS and tested for an improved response ratio (Supple-
mentary Figure S6A). Yet, instead of improving riboswitch
functionality by increasing -galactosidase activity in the
presence of both ligands, constructs TheoTet-RS-15 nt and
TheoTet-RS-20 nt also responded to theophylline alone,
whereas TheoTet-30 nt switched off gene expression alto-
gether (Supplementary Figure S6).
In conclusion, the tandem constructs clearly show that
it is possible to generate Boolean logic gates from syn-
thetic transcriptional riboswitch elements. As observed for
tandem theophylline riboswitches, it seems that the down-
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stream located module has the strongest impact on the re-
sponse ratio (33).
DISCUSSION
Over the last years, riboswitches have increasingly gained
attention in the field of synthetic biology, as they allow con-
ditional control of gene expression by external ligands, rep-
resenting a versatile tool for reprogramming of cells (54–
56). The combination of in vitro generated aptamer domains
specific for a whole plethora of target molecules with suited
regulatory domains opens the principle possibility to gener-
ate custom-designed orthogonal devices regulating gene ex-
pression in pro- and eukaryotes (57,55,10,58,59). However,
the application of such aptamers as synthetic riboswitches
is a rather difficult task. First, suitable effector domains
have to be generated or - in the case of natural compounds
- identified. Batey et al. successfully constructed chimeric
riboswitches by combining different aptamers with expres-
sion platforms of natural riboswitches (24,9). Natural ap-
tamer domains can be used as well and developed into or-
thogonal riboswitches binding ligand analogues not present
in the cell (25,26).
Our approach is based on a complete de novo design
coupled with structure-guided experimental optimization,
where artificial aptamers are fused to a designed transcrip-
tion terminator element. This approach was very success-
ful with a theophylline aptamer-based riboswitch in the
context of different promoters and reporter genes (33,19).
Here, we show that this approach can be applied to de-
sign tetracycline-dependent riboswitches acting on tran-
scription. While individual tetracycline riboswitches are
functional, they exhibit regulatory properties that are dif-
ferent from those of the in silico predicted theophylline ri-
boswitches. For both Theo-RS and Tet-RS constructs, the
reporter gene induction led to a comparable enzymatic ac-
tivity of -galactosidase of 60 (Theo-RS10shift) (19) to 70
MU (Tet-RS1; Figure 2A). The background activation in
the absence of the ligands, however, is different. Without
theophylline, the Theo-RS construct results in 10 MU of -
galactosidase activity, while the individual Tet-RS devices
show a background enzyme activity of 20 to 40 MU (Fig-
ure 2A). Accordingly, the response ratios for tetracycline
constructs are only in a range of 1.5- to 2.2-fold, whereas
Theo-RS10shift is responding in a 6.5-fold ratio (19).
Due to the larger size of the tetracycline aptamer com-
pared to the theophylline-binding structure, the Tet-RS
constructs require a somewhat different composition. The
free energy of the tetracycline aptamer is much lower than
that for the theophylline aptamer (−19.8 versus −12.2
kcal/mol). Accordingly, the terminator hairpin has to ex-
hibit an increased stability that can compete with the ap-
tameric structure to allow a ligand-dependent re-folding of
the RNA. As a result, the terminator hairpins are longer in
sequence than those of theophylline riboswitches. In partic-
ular, they consist of 21 to 23 base pairs and cover a large
region of the aptamer 3′-part (Figures 1B and 2). In the
theophylline constructs, the optimization of the response
ratio correlates with G values in an intermediate range,
relative to the stability of the aptamer structure. Weak ter-
minator hairpins are unable to disrupt aptamer formation,
whereas too stable terminators inhibit a refolding of the ri-
boswitch into the ON state (33,19). This basic principle is
also true for tetracycline-dependent riboswitch constructs.
A successive shortening of the aptamer reverse complemen-
tary sequence reduces the number of base pairs in the ter-
minator structures. This experimental fine-tuning increases
the response ratio up to 3.4-fold in Tet-RS2-15. A further
truncation of the terminator in Tet-RS2-10, however, com-
pletely abolishes ligand-dependent gene activation. Here,
the hairpin stability is too weak to compete with the ap-
tamer fold. As a result, Tet-RS2-10 represents a constitu-
tive ON state (Figure 2B). This behavior of Tet-RS2-10 in-
dicates that these tetracycline riboswitches regulate gene ex-
pression at the level of transcription, as it was also shown
for Theo-RS constructs (19,33). Furthermore, riboswitches
carrying the miniaturized version of the tetracycline ap-
tamer (Tet-RS1M, Supplementary Figure S2) show a func-
tionality identical to that of constructs with the original ap-
tamer (Tet-RS1). This is due to the fact that the minimeric
form of the tetracycline aptamer has a stability that is highly
similar to that of the full-length aptamer (−17.6 kcal/mol
versus −19.8 kcal/mol). In both constructs, the overlapping
region is identical and spans 21 bases of the aptamers 3′-
ends (Figure 2). Hence, the terminator hairpin competes in
both riboswitch forms with the same structure as well as se-
quence part.
For the theophylline-dependent riboswitches, a serial ar-
rangement of two and three copies resulted in a greatly im-
proved response ratio, as the increased number of transcrip-
tional terminators dramatically reduced background acti-
vation in the absence of the ligand (33). The same principle
holds true for the Tet-RS arrangements (Figure 2C), where
we could observe a more than 3-fold increase in the respon-
siveness of the TetTetTet-RS construct compared to the
monomer. The absolute gene expression levels (MU), how-
ever, are slightly reduced the more riboswitch repeats are
introduced. As the functional principle of intrinsic termi-
nators indicates that RNA polymerase is sensitive to stable
secondary structures in the nascent transcript (60), it is pos-
sible that the now highly structured 5′-UTR reduces the rate
of transcription to some degree. Likewise, the riboswitch
structures might diminish ribosome assembly at the neigh-
boring ribosomal binding site. Yet, the serial arrangement
of transcriptional riboswitches seems to be a general strat-
egy to improve the ligand-dependent response, although
these constructs need higher ligand concentrations for full
activation, as all aptamer domains have to bind their ligand
for disrupting their terminator structures.
However, not all design principles suited for theophylline
riboswitches can be transferred to tetracycline riboswitches.
For example, insertion of a GAAA tetraloop into the termi-
nator hairpin of Theo-RS10 lead to a better ON-OFF ra-
tio due to its helix-stabilizing effect (33). In a Tet-RS2-15,
a corresponding loop completely inactivates the riboswitch
(Supplementary Figure S5). Obviously, the long termina-
tor hairpin with a GAAA tetraloop is too stable to allow
a refolding of the tetracycline aptamer, leading to a consti-
tutive OFF state. Similarly, the introduction of additional
GC base pairs in the terminator hairpin inhibits the ON
state formation. These results demonstrate that an intrin-
sic terminator operates context-dependent and cannot be
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simply transferred into different sequence or structural en-
vironments (61,47,62). As a consequence, the applicability
of computer-based predictions still has to be tested and op-
timized experimentally.
While the functionality of the synthetic riboswitches car-
rying a tetracycline aptamer show that our approach is not
restricted to theophylline-sensing regulatory elements, ex-
panding this design principle to riboswitches based on a
streptomycin aptamer is difficult. Except Strep-RS7, the de-
signed constructs did not respond to the presence of strep-
tomycin, suggesting the predicted interaction between ap-
tamer and terminator conformations is impaired in vivo
(Figure 3). While the predicted most stable aptamer struc-
ture has a free energy of −12.5 kcal/mol, the stability of
the selected terminator hairpins varies from −20.7 (Strep-
RS1) to −27.7 kcal/mol (Strep-RS8; the contribution of
the bound ligand was not taken into account). In Strep-
RS1, carrying the weakest terminator element, the reporter
gene was constitutively switched on, resulting in 30 to 40
MU (Figure 3). In contrast, all riboswitches with more sta-
ble terminators were in a constitutive OFF state, and only
Strep-RS7 showed a slight regulatory potential, and a fur-
ther destabilization of the terminator did not improve the
response. Hence, although a considerable range of termi-
nator stabilities was investigated, no substantial regulatory
potential was observed. Even though this result seems to
contradict the universality of our design pipeline, there are
several possible scenarios explaining the observation. First,
the structure probing data do not support the existence of
the predicted MFE structure, and the candidates adopt an
alternative––less stable––structure of the calculated folding
tree (Figure 4). However, the terminator elements were de-
signed to compete with the MFE structure and obviously do
not allow a refolding of the aptamer into the ligand-binding
competent state. Only the terminator of Strep-RS7 shows
some compatibility. In Strep-RS1, on the other hand, the
designed hairpin is either not stable enough to be formed
in vivo or is not functional as a terminator, resulting both a
constitutive ON state. Here, in addition to free energy con-
siderations, incorporating the aptamer fold that has been
reported on the basis of structure probing and/or crystal-
lization should allow a further improvement in the design
of synthetic riboswitches (35,63).
A second reason for the malfunction of the Strep-RS
constructs might be the relatively low affinity of the strep-
tomycin aptamer with a Kd of ∼1 M (35). In contrast,
the aptamers for theophylline and tetracycline bind their
ligands with Kd values of 0.32 M and 770 pM, respec-
tively (64,40). Hence, these aptamers might be more suit-
able for an in vivo application in synthetic riboswitches than
the streptomycin aptamer. A third possibility lies in the ba-
sic principle of aptamer generation that selects for a tight
binding potential of RNA but not for its suitability for ri-
boswitch regulation (58). The Süß lab introduced neomycin
aptamers as regulatory translational roadblocks into the
5′-UTR of a GFP reporter gene in yeast. The in vitro se-
lected aptamer R23 showed no ligand-induced regulation,
while an in vivo screened aptamer N1 allowed a neomycin-
dependent translation (14,65). Aptamer R23 has a stable
pre-formed binding pocket even in the absence of neomycin
and shows no structural rearrangement upon ligand bind-
ing. Aptamer N1, however, exhibits a more dynamic behav-
ior upon ligand interaction. The structure of the unbound
aptamer seems to be less stable, allowing the scanning ribo-
somes to proceed and reach the translation start site, and
translation is turned on. In contrast, the robust structure
of the unbound R23 aptamer obviously is too stable for
being disrupted by the ribosomes, and translation ceases
(14,41,66). It is possible that the streptomycin aptamer also
forms such a pre-folded stable structure in the Strep-RS
constructs, inhibiting a refolding of the riboswitches upon
ligand binding. Yet, the weakly ligand-responding Strep-
RS7 indicates that the riboswitch-suitability of an aptamer
seems to be context-dependent, and that a competing ter-
minator hairpin of equal stability could destabilize the pre-
formed aptamer structure in the absence of the ligand. In
translational road block riboswitches, this is not possible,
as there is no additional structural element competing with
the aptamer fold. However, due to the observed low ligand
response, the formation of this alternative folding seems to
be quite inefficient in Strep-RS7 and aptamers with a pro-
nounced refolding could represent better candidates also for
riboswitches with a terminator-forming expression module.
In summary, it is not clear yet whether the failure to design
streptomycin-dependent riboswitches represents the limita-
tions of the current computational design approach or the
streptomycin aptamer with a stable pre-formed structure in
the absence of the ligand is simply not suited for riboswitch
construction.
Nevertheless, the functionality of the Tet-RS constructs
demonstrates that our in silico design can be applied to dif-
ferent aptamers, even though only one of the Strep-RS con-
structs shows a moderate functionality. Hence, for aptamers
that do not adopt the calculated MFE structure (like the
streptomycin aptamer), the design strategy has to be mod-
ified so that it is not restricted to the MFE structure but
uses a defined aptamer fold as a constraint. With such a
modification, it should be possible to generate further ri-
boswitch elements with sensor platforms forming less stable
structures than predicted by RNAfold. Here, knowledge of
the aptamer structure by crystallography or, even better, by
structural data of the RNA in solution (NMR, SHAPE, in-
line probing) is required. Yet, structure-guided experimen-
tal optimization as shown above is still necessary to obtain
efficient activation ratios in these synthetic regulators.
The fact that the tetracycline aptamer could be com-
bined with terminator constructs to form functional ri-
boswitches offered the opportunity to generate heteroge-
neous riboswitch tandems acting on transcription. While
the 2- and 3-fold arrangement of theophylline riboswitches
was shown to dramatically increase the response ratio and
leads to a linear dose-dependent gene activation (33), the
combination of synthetic riboswitches sensing different lig-
ands leads to a very different regulatory principle, acting as
a logic ‘AND’ gate that is fully activated only in the presence
of both ligands. Similar tandem riboswitches have been gen-
erated with different expression platforms regulating trans-
lation, like a cis-acting ribozyme that destroys the mRNA
(50,51), a ribosomal binding site sequestor (52) or a se-
quence capable of ribosomal frameshift (53). Our TheoTet-
RS combinations, however, act on transcription, allowing a
faster response, as an early step of gene expression is regu-
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lated. While these tandems demonstrate that the individual
riboswitch elements can be freely combined, the results in-
dicate that additional parameters affecting the functional-
ity have to be considered. First, the sequential order of the
individual Theo- and Tet-RS lead to different response ef-
ficiencies. TheoTet-RS shows a ligand-dependent response
similar to synthetic ‘AND’ gates acting on translation (50),
with a low background activation in the presence of only
one ligand (Figure 5). In contrast, TetTheo-RS, represent-
ing the reverse riboswitch order, shows an increase back-
ground activation in the presence of theophylline. Here, the
Tet-RS element should be in the OFF state and terminate
transcription. While the observed background activity cor-
responds to that of the individual Tet-RS2-15 (Figure 2), the
same riboswitch seems to shut off transcription more effi-
ciently when being located downstream of Theo-RS. Obvi-
ously, both riboswitch elements have an impact on the func-
tionality of their neighboring construct, and an increase of
the distance by introducing linker regions between both ri-
boswitches could not reduce this effect (Supplementary Fig-
ure S6). Hence, the individual components of these tandem
arrangements cannot be regarded as independent building
blocks, and it will be important to expand the design algo-
rithm to include possible interactions between the modules
that disturb correct folding into individual aptamer and ter-
minator conformations.
Taken together, our results show that rational design of
synthetic riboswitches can be expanded to different ap-
tamers, although further improvements of the approach are
required to allow the use of non-MFE-like structures and
different tandem arrangements. While there are alternative
strategies available, like adaptation of natural platforms and
screening of libraries of randomized RNA sequences, the
de novo construction is essential to identify important de-
sign parameters in order to understand the functionality
of riboswitches and their required ligand-dependent refold-
ing in detail. Design strategies regulating gene expression
via trans-acting RNAs like toehold switches (29) and small
trans activating RNAs (30) are also very promising ap-
proaches. However, OFF target effects of the trans-acting
RNAs can impair the usability of these systems. In addi-
tion, stoichiometric effects have to be considered, as a cer-
tain concentration of the trans-acting RNA is required for
finding and binding its target. Finally, features identified
in a rational design strategy not only facilitate the in sil-
ico construction of functional riboswitches, but will also be
transferable into the design of these alternative regulatory
RNA constructs, deepening our understanding of RNA-
based gene regulation in nature as well as in synthetic bi-
ology.
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Supplementary Data are available at NAR Online.
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